Clinical Trials Logo

Filter by:
NCT ID: NCT06424353 Recruiting - Postoperative Pain Clinical Trials

Postoperative Pain After Pulpectomy of Primary Molars

Start date: January 20, 2024
Phase: N/A
Study type: Interventional

Testing postopertive pain after pulpectomy of primary molars with endoflas using modified Wong-Baker scale of pain.

NCT ID: NCT06424093 Recruiting - Anxiety Clinical Trials

Effect of Virtual Reality Technology for Managment of Acute Pain in Outpatient Hysteroscopy

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

Performing out patient diagnostic and operative gynecological procedures is becoming more popular having the benefits of reducing risks of general anaesthetia, decreasing healthcare burden and increasing satisfaction for both patient and provider. Virtual reality (VR), a new technology, has been studied as a distraction technique for non-pharmacological method of pain relief. It is a computer-generated representation of an immersive videos viewed through a headset.

NCT ID: NCT06424080 Recruiting - Clinical trials for Renal Cell Carcinoma

Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

partial nephrectomy offers lower renal function impairment and equivalent oncological survival outcomes compared with radical nephrectomy in those with T1 tumors. As urology has embraced the gradual shift from open to minimally invasive surgery (MIS), PN is being completed more often by laparoscopic and robotic methods . The first laparoscopic transperitoneal partial nephrectomy was reported in 1993 by Winfield, with the retroperitoneal approach introduced 1 year later With advancing robotic technology and the development of the DaVinci system, urologists began to explore the realm of robotic-assisted urologic surgery. In 2004, Gettman et al. published a paper describing their experience with robotic-assisted laparoscopic partial nephrectomy. Moreover, robotic assisted partial nephrectomy (RAPN) and laparoscopic partial nephrectomy (LPN) seems to be significantly better than OPN in terms of perioperative complications, estimated blood loss and hospital stay. Conversely, transfusion rate, ischemia time, change in estimated glomerular filtration rate and early cancer outcomes are similar between the two approaches. International guidelines recommend the use of both approaches according to the surgeon and patient preferences. so, we are plaining to do the study comparing between RAPN and LPN regarding feasibility and ability of both techniques.

NCT ID: NCT06423859 Recruiting - Clinical trials for Post Operative Pain, Acute

Articaine Plus Dexmedetomidine in Supraclavicular Block

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

Articaine has emerged as a local anesthetic (LA) that produces sensory and motor blockade shorter than bupivacaine and lower in neurotoxicity than lidocaine. Studies have shown that adding dexmedetomidine to LA produces prolongation of sensory and motor bock duration. Early regain of motor power with adequate analgesia is needed in ambulatory surgery, for early start of physiotherapy. This study was designed to test efficacy of adding dexmedetomidine to articaine on the duration of sensory and motor block.

NCT ID: NCT06423833 Recruiting - Clinical trials for High-Risk Surgical Patients

Trendelenburg Maneuver Versus Passive Leg Raising Test for Fluid Responsiveness in High-Risk Surgical Patients

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate whether Trendelenburg maneuver can be used to predict fluid responsiveness in high-risk surgical patients in intensive care unit as compared to Passive Leg Raising test.

NCT ID: NCT06423820 Recruiting - Clinical trials for Postoperative Nausea and Vomiting

Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Pediatrics Undergoing Squint Surgeries

Start date: May 21, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the role of ondansetron lozenge on prevention of postoperative nausea and vomiting (PONV) in pediatrics undergoing squint surgeries.

NCT ID: NCT06423807 Recruiting - Cesarean Section Clinical Trials

Preoperative Ondansetron Lozenge for Prevention of Post-Spinal Shivering in Caesarean Section

Start date: May 21, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to estimate the role of ondansetron lozenge on prevention of post-spinal shivering in cesarean section.

NCT ID: NCT06423729 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Effect of Nicorandil in Type 2 Diabetic Obese Patients

Start date: June 1, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

1. Evaluating the effect of nicorandil on glycemic control of diabetic obese patients treated with sulfonylureas. 2. Investigating the effect of nicorandil on body weight of diabetic obese patients treated with sulfonylureas.

NCT ID: NCT06423482 Recruiting - Clinical trials for Digitalization Accuracy

Digitization Accuracy and Scannability of Two Different Implant-Supported Prosthodontic Framework Materials

Start date: May 14, 2024
Phase: N/A
Study type: Interventional

The present study aims to clinically evaluate and compare the scanning accuracy and the scannability of 2 different materials used in constructing frameworks for implant-supported prosthesis (titanium and PEEK). The objective of the present study is to evaluate the digitization accuracy and scannability of milled titanium and PEEK implant-supported frameworks in intra-oral conditions and to evaluate the accuracy of the superstructures designed and constructed over the intraorally scanned framework.

NCT ID: NCT06423339 Recruiting - Post Operative Pain Clinical Trials

Comparison Between Genicular Nerve Block Combined With (IPACK) Block Versus Adductor Canal Block

Start date: May 10, 2024
Phase: N/A
Study type: Interventional

The patients will be randomized into 2 groups, named group A, B. Group A: The patients will receive Ultrasound guided Genicular nerves block combined with Ultrasound guided IPACK block. Group B: The patients will receive Adductor canal block which will be the control group. The Numerical Rating Scale (NRS) will be used to assess pain intensity. Preoperatively, all study subjects will be trained to use NRS pain scores. The spinal block will be performed. In group A, 15 mL of bupivacaine 0.25% with 2.5 g/mL adrenaline at a concentration 1:4,00,000 will be administered immediately following skin closure. GNB will be performed by using the linear ultrasound probe (10-15 MHz) Sono site M-turbo ultrasonography to scan the long bone shaft with up and down movement to recognize the epicondyle of the tibia and femur. The junctions between the epicondyle and the shafts of the femur and tibia are where the genicular arteries are located; these junctions will be defined as the periosteal areas. The superior lateral, superior medial and inferior medial genicular arteries accompany each genicular nerve. After confirmation of the genicular artery by color Doppler, the needle will be introduced using the in-plane approach and presented in the long axis view. The target point of the needle insertion will be the needle tip beside a genicular artery. Then, a 5 mL volume will be administered after gentle aspiration to prevent a faulty intra-arterial injection at 3 target locations: the superior lateral, superior medial and inferior medial genicular nerves. This will be Followed by the procedure for the IPACK block. In group B, A 22 Gauge 80 mm needle will be guided from lateral to medial to this area called the adductor canal using in-plane technique. 20 mL of 0.5% bupivacaine will be injected with peri-arterial spread after negative aspiration under sterile conditions. TKA will be performed by an orthopedic surgeon by placing three-compartment prostheses with a minimally invasive mini-midvastus approach and using hand-mixed cementing techniques.